Annual Changes to the NASDAQ Biotechnology Index

Dec 13, 2019

NEW YORK, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) today announced the results of the annual evaluation of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 23, 2019.

The following 40 securities will be added to the Index:

Nasdaq ADMA ADMA Biologics Inc.
Nasdaq ADPT Adaptive Biotechnologies Corp.
Nasdaq AFMD Affimed NV
Nasdaq AKRO Akero Therapeutics Inc.
Nasdaq ALEC Alector Inc.
Nasdaq ALLO Allogene Therapeutics Inc.
Nasdaq ARDX Ardelyx Inc.
Nasdaq ARVN Arvinas Inc.
Nasdaq ASMB Assembly Biosciences Inc.
Nasdaq AXNX Axonics Modulation Technologies Inc.
Nasdaq AXSM Axsome Therapeutics Inc.
Nasdaq BBIO BridgeBio Pharma Inc.
Nasdaq BCEL Atreca Inc.
Nasdaq BDSI BioDelivery Sciences International Inc.
Nasdaq CGEN Compugen Ltd.
Nasdaq CHMA Chiasma Inc.
Nasdaq CSTL Castle Biosciences Inc.
Nasdaq DTIL Precision BioSciences Inc.
Nasdaq GH Guardant Health Inc.
Nasdaq GMAB Genmab A/S
Nasdaq GOSS Gossamer Bio Inc.
Nasdaq GRTS Gritstone Oncology Inc.
Nasdaq KOD Kodiak Sciences Inc.
Nasdaq KRTX Karuna Therapeutics Inc.
Nasdaq MGTX MeiraGTx Holdings plc
Nasdaq MRNA Moderna Inc.
Nasdaq NGM NGM Biopharmaceuticals Inc.
Nasdaq ORTX Orchard Therapeutics plc
Nasdaq OSMT Osmotica Pharmaceuticals PLC
Nasdaq PRNB Principia Biopharma Inc.
Nasdaq PRVL Prevail Therapeutics Inc.
Nasdaq PSNL Personalis Inc.
Nasdaq PTGX Protagonist Therapeutics Inc.
Nasdaq SNY Sanofi
Nasdaq SRRK Scholar Rock Holding Corp.
Nasdaq STOK Stoke Therapeutics Inc.
Nasdaq TPTX Turning Point Therapeutics Inc.
Nasdaq TWST Twist Bioscience Corp.
Nasdaq XBIT XBiotech Inc.
Nasdaq YMAB Y-mAbs Therapeutics Inc.

The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (NASDAQ®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB).

As a result of the evaluation, the following 36 securities will be removed from the Index:

Nasdaq ABUS Arbutus Biopharma Corp.
Nasdaq ACOR Acorda Therapeutics Inc.
Nasdaq ACRS Aclaris Therapeutics Inc.
Nasdaq ACRX AcelRx Pharmaceuticals Inc.
Nasdaq ADAP Adaptimmune Therapeutics Plc
Nasdaq ADMS Adamas Pharmaceuticals Inc.
Nasdaq ADRO Aduro Biotech Inc.
Nasdaq APTX Aptinyx Inc.
Nasdaq AQST Aquestive Therapeutics Inc.
Nasdaq ASRT Assertio Therapeutics Inc.
Nasdaq AXGT Axovant Gene Therapies Ltd.
Nasdaq CLVS Clovis Oncology Inc.
Nasdaq CNCE Concert Pharmaceuticals Inc.
Nasdaq CRNX Crinetics Pharmaceuticals Inc.
Nasdaq DBVT DBV Technologies SA
Nasdaq ELOX Eloxx Pharmaceuticals Inc.
Nasdaq FPRX Five Prime Therapeutics Inc.
Nasdaq KALA Kala Pharmaceuticals Inc.
Nasdaq KNSA Kiniksa Pharmaceuticals Ltd.
Nasdaq MNOV MediciNova Inc.
Nasdaq NERV Minerva Neurosciences Inc.
Nasdaq NVAX Novavax Inc.
Nasdaq OCUL Ocular Therapeutix Inc.
Nasdaq PRTK Paratek Pharmaceuticals Inc.
Nasdaq PTI Proteostasis Therapeutics Inc.
Nasdaq REPL Replimune Group Inc.
Nasdaq SBBP Strongbridge Biopharma PLC
Nasdaq STIM Neuronetics Inc.
Nasdaq SURF Surface Oncology Inc.
Nasdaq SVRA Savara Inc.
Nasdaq SYBX Synlogic Inc.
Nasdaq TOCA Tocagen Inc.
Nasdaq UMRX Unum Therapeutics Inc.
Nasdaq VSTM Verastem Inc.
Nasdaq XENE Xenon Pharmaceuticals Inc.
Nasdaq ZFGN Zafgen Inc.

About Nasdaq Global Indexes

Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Dorsey Wright, Fixed Income (includes BulletShares®), Global Equity, Green Economy, Nordic and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide-spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index and design solutions to financial organizations worldwide.

About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at

The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq’s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

Media Contacts: Matthew Sheahan, Nasdaq
(212) 231-5945

Issuer & Investor Contact: Index Client Services
(844) 717-0708



Source: Nasdaq, Inc.

Scroll up